Nav: Home

Scientists at the CNIO have deconstructed 1 of the myths of biological innovation

October 03, 2016

While the number of coding genes (those that produce proteins) in the human species has been consistently dwindling in recent years - the figures have fallen to fewer than 20,000-, it has been claimed that the dimension of the proteome, the element that executes the instructions in the genome, could be larger. This diversity of proteins has become one of the main sources of complexity in mammals, including the human species.

This theory could have an expiry date according to a study headed by the researcher Michael Tress from Alfonso Valencia's group at the Spanish National Cancer Research Centre (CNIO), published today in the journal Trends in Biochemical Sciences (TIBS). According to the researchers, most genes produce, against the prevailing opinion, a single dominant protein. These results require the reassessment of the origin and source of biological innovation, which led to the emergence of primates 50 million years ago or to the development of the human brain, for example.

RESIZING THE HUMAN PROTEIN MAP

"The diminishing human genome" is how Valencia described the continuous corrections to the annotations of the human genome more than two years ago. Then, his team set the number of genes at around 19,000. Can something as complex as a human being be built from such a small number of genes?

Many researchers, sceptical about this issue, have turned their attention to the proteome as a possible source of biological innovation. Each gene can produce up to dozens or hundreds of RNAs, which result from combinations of various portions of a gene through alternative splicing. Then, the RNAs are translated into proteins. That is why alternative splicing has been identified as an important source of protein diversity.

In this chain of life, from the gene to RNA and from RNA to a protein, the authors of the paper realised there was a vast difference between the number of RNAs or transcripts, of the order of hundreds of thousands in humans, while the number of proteins, quantified experimentally, amounted to little more than 12,000. "The problem is the huge number of transcripts led us to assume there is a larger number of proteins, but the presence of all of them within the cells has never been demonstrated", explains Michael Tress, principal investigator on the project.

"One gene, one protein, or one gene, several proteins?" the researchers ponder in the pages of the magazine. To answer this question, they conducted a comprehensive meta-analysis compiling data from eight large-scale experiments and from proteins or human peptide databases. The data analysed came from a wide range of tissues, cell lines and from different development stages.

The results show that while there are many alternative variants of RNAs from a single gene, only a few genes (246, slightly more than 1 per cent of the human genome) presented clear evidence of producing more than one protein. "Most genes produce a single dominant protein. This tells us that alternative splicing is not essential for the complexity of the proteome", explains Tress. According to the authors, when alternative splicing takes place it generates highly conserved proteins, with evolutionary origins that can go back more than 500 million years and with very subtle changes in their structure and function.

PREDICTING THE CONSEQUENCES OF DIFFERENT GENETIC VARIANTS

These observations may have significant implications in biomedicine, particularly in predicting the effects of genetic variants or mutations in the body. The team suggests that only the mutations in the DNA that have an impact on the dominant proteins will be detrimental.

Despite the limited evidence of alternative splicing in healthy cells, the situation is different with diseases such as cancer, in which this process plays a fundamental role in generating new forms of proteins with aberrant functions that compromise the viability of the organism.

Researchers are now pondering on the existence of all those RNAs for which no proteins have been detected and, therefore, for which we currently have no defined biological function. Could it be lost information? Useless information? Do they play new regulatory roles still to be discovered? For now, there are questions that science is facing for which there are no answers.
-end-
This paper has been funded by the US National Institute of Health (NIH).

Centro Nacional de Investigaciones Oncológicas (CNIO)

Related Cancer Articles:

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Meditations on Loneliness
Original broadcast date: April 24, 2020. We're a social species now living in isolation. But loneliness was a problem well before this era of social distancing. This hour, TED speakers explore how we can live and make peace with loneliness. Guests on the show include author and illustrator Jonny Sun, psychologist Susan Pinker, architect Grace Kim, and writer Suleika Jaouad.
Now Playing: Science for the People

#565 The Great Wide Indoors
We're all spending a bit more time indoors this summer than we probably figured. But did you ever stop to think about why the places we live and work as designed the way they are? And how they could be designed better? We're talking with Emily Anthes about her new book "The Great Indoors: The Surprising Science of how Buildings Shape our Behavior, Health and Happiness".
Now Playing: Radiolab

The Third. A TED Talk.
Jad gives a TED talk about his life as a journalist and how Radiolab has evolved over the years. Here's how TED described it:How do you end a story? Host of Radiolab Jad Abumrad tells how his search for an answer led him home to the mountains of Tennessee, where he met an unexpected teacher: Dolly Parton.Jad Nicholas Abumrad is a Lebanese-American radio host, composer and producer. He is the founder of the syndicated public radio program Radiolab, which is broadcast on over 600 radio stations nationwide and is downloaded more than 120 million times a year as a podcast. He also created More Perfect, a podcast that tells the stories behind the Supreme Court's most famous decisions. And most recently, Dolly Parton's America, a nine-episode podcast exploring the life and times of the iconic country music star. Abumrad has received three Peabody Awards and was named a MacArthur Fellow in 2011.